Market by Product Type, Application, and Regional Outlook | Forecast 2022-2028
Medical enzymes are prodrugs that target a particular biological
irreversible or reversible reaction in order to treat a condition. These
enzymes include cysteine proteinases, streptokinase, urokinase, pegademase, and
others. They are used in clinical diagnosis and as therapeutic agents to treat
cancer, metabolic ailments, and lysosomal diseases, which is expected to
benefit the market’s growth.
According to Triton Market Research’s report, the Global Medical Enzymes Market is likely to reach $6878.46 million by 2028 from $4355.27 million in 2021, with a CAGR of 6.78% during the forecast period 2022-2028.
Click here to check out our blog on the Global Medical Enzymes Market
MARKET PERFORMANCE – DRIVERS,
CHALLENGES, AND TRENDS
The demand for medical enzymes is expected to
grow with the rising prevalence of digestive disorders due to poor dietary
habits, obesity, smoking and tobacco consumption, and rising health awareness. Moreover, increased investments in research
and development are expected to support the market’s growth. The rising
geriatric population is associated with a high risk of chronic diseases. As per
WHO, one in every six people globally is expected to be more than 60 years by
2030.
However, the strict regulations associated with
medical enzymes and security concerns while handling these enzymes are factors
hampering the market’s growth.
Medicinal products are subjected to Regulation (EEC) 2309/93 and Directive
65/65/EEC. In this regard, improper handling raises various safety issues that
reduce the demand for medical enzymes to a large extent, creating challenges
for market players.
Nevertheless, the development of therapeutics
and technological advancements to engineer enzymes for various pharmaceutical
applications are expected to create opportunities for the medical enzymes
market. For instance,
machine learning technology helps improve the performance of enzymes by
lowering time and resources.
Report scope can be customized per your requirements. Request For Customization
KEY GEOGRAPHIES COVERED:
● North America: United States and Canada
● Europe: United Kingdom, France, Germany, Spain, Italy, and Rest of Europe
● Asia-Pacific: China, Japan, India, Australia & New Zealand, South Korea, ASEAN Countries, and Rest of Asia-Pacific
● Latin America: Brazil, Mexico, and Rest of Latin America
● Middle East and Africa: Saudi Arabia, Turkey, United Arab
Emirates, South Africa, and Rest of Middle East & Africa
SEGMENTATION
ANALYSIS – MEDICAL ENZYMES MARKET
• Market by Product type:
o Hydrolase
• Hyaluronidase
• Lysozymes
• Other Hydrolases Enzymes
o Thrombolytic Enzyme
• Streptokinase
• Urokinase
• Other Thrombolytic Enzymes
The
thrombolytic enzyme is expected to emerge as the fastest-growing segment during
the forecast period.
These enzymes are used to treat and diagnose blood clots at an early stage. Streptokinase finds
applications in preventing postoperative adhesions, a common
complication of surgery, especially in the case of abdominal surgery and
dissolves blood clots formed in blood vessels. The streptokinase enzyme
category is anticipated to witness significant growth, owing to its
applications in clinical medicines to treat thromboembolic blockages, including
coronary thrombosis.
o Digestive Enzyme
• Lactase
• L-Asparaginase
• Other Digestive Enzymes
o Endonuclease
• Benzonase
• Other Endonucleases
• Market by Application:
o Disease Treatment
The disease treatment category is anticipated to
witness the fastest growth over the forecast period. The medical enzymes market finds application
in the treatment of various diseases such as gastrointestinal disorders,
cardiovascular diseases and coagulation disorders, and cancer therapy. For
example, the activity of lysozymes against HIV can be used to treat HIV
infection, alglucerase is used for treating gaucher disease, and pegademase
bovine is used for the treatment of severe combined immunodeficiency.
o Diagnostic Tools
o Biomedical Research
o Other Applications
COMPETITIVE LANDSCAPE:
The medical enzymes market by company profile helps dive into data about
the key players in this industry. The strategic initiatives for each of the
companies considered have been covered in detail.
Collaboration (November 2021)
Novozymes and Novo Nordisk Pharmatech
Novozymes and Novo Nordisk Pharmatech signed a collaboration agreement
to develop superior quality enzymes.
Product Development (March
2021) Amano Enzyme
Amano Enzyme launched Umamizyme Pulse, a non-GMO enzyme used in plant
protein products to enhance flavor.
Key Benefits of the Report:
● Triton Market Research has a collective experience of 25-30 years
in the industry, with its analysts and experts encompassing the most infallible
research methodology for its market intelligence and industry analysis.
● Our research methodology helps in achieving a broader consensus of
the market size, shape, and industry trends within each industry segment.
● The strategy adopted in designing the research methodology
includes the amalgamation of the information assembled from primary and
secondary sources, with the assistance of analytical tools to construct the
forecast and predictive models.
● The scope of the market report comprises the current scenario of
the global medical enzymes market, along with a detailed overview of the
industry outlook, market dynamics, segmentation analysis, regional outlook, and
competitive landscape for the period 2022-2028.
FAQs:
Q 1) What are diagnostic
enzymes?
Medical enzymes provide insights into various diseases
through diagnosis, prognosis, and assessment of the response therapy. Commonly
assayed enzymes to diagnose diseases include alkaline phosphatase, creatine
kinase, aminotransferases, and dehydrogenases.
Q 2) What is the use of
restriction enzymes?
The restriction enzymes are useful to dissect, analyze, and restructure
DNA in a site-specific and controlled manner.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
MEDICAL ENZYMES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL ENZYMES MARKET
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN ENZYME ENGINEERING
2.2.2. INCREASED
DEMAND IN THE PHARMACEUTICAL SECTOR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. PRICE
2.4.2. QUALITY
2.4.3. USAGE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.7.1. RESEARCH
AND DEVELOPMENT
2.7.2. OPERATIONS
2.7.3. OUTBOUND
LOGISTICS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES & DEVELOPMENTS
2.9.3. PARTNERSHIPS
& AGREEMENTS
2.9.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. RISING
INVESTMENTS IN RESEARCH AND DEVELOPMENT
2.10.2. RISING
AGEING POPULATION AND OCCURRENCE OF CHRONIC DISEASES
2.10.3. INCREASING
APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY
2.11. MARKET
CHALLENGES
2.11.1. STRICT
REGULATIONS
2.11.2. SAFETY
CONCERNS WHILE HANDLING ENZYMES
2.12. MARKET
OPPORTUNITIES
2.12.1. RISING
HEALTH ISSUES AND GROWING AWARENESS
2.12.2. RISING
DEMAND FOR SPECIALTY ENZYMES
3. GLOBAL
MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE
3.1. HYDROLASE
3.1.1. HYALURONIDASE
3.1.2. LYSOZYMES
3.1.3. OTHER
HYDROLASES ENZYMES
3.2. THROMBOLYTIC
ENZYME
3.2.1. STREPTOKINASE
3.2.2. UROKINASE
3.2.3. OTHER
THROMBOLYTIC ENZYMES
3.3. DIGESTIVE
ENZYME
3.3.1. LACTASE
3.3.2. L-ASPARAGINASE
3.3.3. OTHER
DIGESTIVE ENZYMES
3.4. ENDONUCLEASE
3.4.1. BENZONASE
3.4.2. OTHER
ENDONUCLEASES
4. GLOBAL
MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION
4.1. DISEASE
TREATMENT
4.2. DIAGNOSTIC
TOOLS
4.3. BIOMEDICAL
RESEARCH
4.4. OTHER
APPLICATIONS
5. GLOBAL
MEDICAL ENZYMES MARKET – REGIONAL OUTLOOK
5.1. NORTH
AMERICA
5.1.1. MARKET
BY PRODUCT TYPE
5.1.1.1. MARKET
BY HYDROLASE
5.1.1.2. MARKET BY THROMBOLYTIC ENZYME
5.1.1.3. MARKET
BY DIGESTIVE ENZYME
5.1.1.4. MARKET
BY ENDONUCLEASE
5.1.2. MARKET
BY APPLICATION
5.1.3. COUNTRY
ANALYSIS
5.1.3.1. UNITED
STATES
5.1.3.2. CANADA
5.2. EUROPE
5.2.1. MARKET
BY PRODUCT TYPE
5.2.1.1. MARKET
BY HYDROLASE
5.2.1.2. MARKET BY THROMBOLYTIC ENZYME
5.2.1.3. MARKET
BY DIGESTIVE ENZYME
5.2.1.4. MARKET
BY ENDONUCLEASE
5.2.2. MARKET
BY APPLICATION
5.2.3. COUNTRY
ANALYSIS
5.2.3.1. UNITED
KINGDOM
5.2.3.2. GERMANY
5.2.3.3. FRANCE
5.2.3.4. SPAIN
5.2.3.5. ITALY
5.2.3.6. REST
OF EUROPE
5.3. ASIA-PACIFIC
5.3.1. MARKET
BY PRODUCT TYPE
5.3.1.1. MARKET
BY HYDROLASE
5.3.1.2. MARKET BY THROMBOLYTIC ENZYME
5.3.1.3. MARKET
BY DIGESTIVE ENZYME
5.3.1.4. MARKET
BY ENDONUCLEASE
5.3.2. MARKET
BY APPLICATION
5.3.3. COUNTRY
ANALYSIS
5.3.3.1. CHINA
5.3.3.2. JAPAN
5.3.3.3. INDIA
5.3.3.4. SOUTH
KOREA
5.3.3.5. ASEAN
COUNTRIES
5.3.3.6. AUSTRALIA
& NEW ZEALAND
5.3.3.7. REST
OF ASIA-PACIFIC
5.4. LATIN
AMERICA
5.4.1. MARKET
BY PRODUCT TYPE
5.4.1.1. MARKET
BY HYDROLASE
5.4.1.2. MARKET BY THROMBOLYTIC ENZYME
5.4.1.3. MARKET
BY DIGESTIVE ENZYME
5.4.1.4. MARKET
BY ENDONUCLEASE
5.4.2. MARKET
BY APPLICATION
5.4.3. COUNTRY
ANALYSIS
5.4.3.1. BRAZIL
5.4.3.2. MEXICO
5.4.3.3. REST
OF LATIN AMERICA
5.5. MIDDLE
EAST AND AFRICA
5.5.1. MARKET
BY PRODUCT TYPE
5.5.1.1. MARKET
BY HYDROLASE
5.5.1.2. MARKET BY THROMBOLYTIC ENZYME
5.5.1.3. MARKET
BY DIGESTIVE ENZYME
5.5.1.4. MARKET
BY ENDONUCLEASE
5.5.2. MARKET
BY APPLICATION
5.5.3. COUNTRY
ANALYSIS
5.5.3.1. UNITED
ARAB EMIRATES
5.5.3.2. SAUDI
ARABIA
5.5.3.3. TURKEY
5.5.3.4. SOUTH
AFRICA
5.5.3.5. REST
OF MIDDLE EAST & AFRICA
6. COMPETITIVE
LANDSCAPE
6.1. BASF
SE
6.2. DUPONT
6.3. ROCHE
HOLDING AG
6.4. NOVOZYMES
6.5. DSM
6.6. SANOFI
SA
6.7. CODEXIS
6.8. ADVANCED
ENZYMES
6.9. AMANO
ENZYME
6.10. BBI
SOLUTIONS
6.11. THERMOFISHER
SCIENTIFIC INC
6.12. CPC
BIOTECH
6.13. NOVUS
6.14. BRAIN
BIOTECH AG
6.15. SEKISUI
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL MEDICAL
ENZYMES MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: APPLICATIONS
OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY
FRAMEWORK
TABLE 5: LIST OF
MERGERS & ACQUISITIONS
TABLE 6: LIST OF
PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: LIST OF
PARTNERSHIPS & AGREEMENTS
TABLE 8: LIST OF
BUSINESS EXPANSIONS & DIVESTITURES
TABLE 9: MEDICAL
APPLICATION OF VARIOUS ENZYMES
TABLE 10: GLOBAL
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 11: GLOBAL
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 12: GLOBAL
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 13: GLOBAL
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 14: GLOBAL
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
TABLE 15: GLOBAL
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 16: GLOBAL
MEDICAL ENZYMES MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 22: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 23: NORTH AMERICA
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 24: EUROPE
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 25: EUROPE
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE 2022-2028 (IN $ MILLION)
TABLE 26: EUROPE
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 27: EUROPE
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 28: EUROPE
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 29: EUROPE
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 30: EUROPE
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 34: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 35: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 36: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 37: ASIA-PACIFIC
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 38: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 39: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 40: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 41: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 42: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 43: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 44: LATIN AMERICA
MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 45: MIDDLE EAST AND
AFRICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 46: MIDDLE EAST AND
AFRICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 47: MIDDLE EAST AND
AFRICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 48: MIDDLE EAST AND
AFRICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
TABLE 49: MIDDLE EAST AND
AFRICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 50: MIDDLE EAST AND
AFRICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, 2022-2028 (IN $ MILLION)
TABLE 51: MIDDLE EAST AND
AFRICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET
ATTRACTIVENESS INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: GLOBAL
MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 5: GLOBAL MEDICAL
ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL
MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)
FIGURE 7: GLOBAL
MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)
FIGURE 8: GLOBAL
MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL
MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL
MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL MEDICAL
ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)
FIGURE 12: GLOBAL
MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL
MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)
FIGURE 14: GLOBAL MEDICAL
ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)
FIGURE 16: GLOBAL
MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)
FIGURE 17: GLOBAL
MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)
FIGURE 18: GLOBAL
MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)
FIGURE 19: GLOBAL
MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL
MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: GLOBAL
MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN %)
FIGURE 22: GLOBAL
MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)
FIGURE 23: GLOBAL
MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)
FIGURE 24: GLOBAL
MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 25: GLOBAL
MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)
FIGURE 26: GLOBAL
MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)
FIGURE 27: GLOBAL
MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)
FIGURE 28: GLOBAL
MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 29: GLOBAL
MEDICAL ENZYMES MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 30: UNITED
STATES MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: CANADA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: UNITED
KINGDOM MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: GERMANY
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: FRANCE
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: SPAIN
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: ITALY MEDICAL
ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: REST OF
EUROPE MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: CHINA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: JAPAN
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: INDIA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: SOUTH KOREA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: ASEAN COUNTRIES
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: AUSTRALIA
& NEW ZEALAND MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 44: REST OF
ASIA-PACIFIC MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 45: BRAZIL
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: MEXICO
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: REST OF
LATIN AMERICA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 48: UNITED ARAB EMIRATES
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 49: SAUDI ARABIA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 50: TURKEY
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 51: SOUTH AFRICA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 52: REST OF
MIDDLE EAST & AFRICA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)